Clinical Trial Update: Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming [NA]

View source ↗

Summary

A Johns Hopkins-sponsored clinical trial investigating gut microbiome changes, adverse effects, and metabolic markers in breast cancer patients, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Breast Cancer, Early-stage Breast Cancer | NA | Status: RECRUITING